Duxun Tan

553 total citations · 1 hit paper
8 papers, 337 citations indexed

About

Duxun Tan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Duxun Tan has authored 8 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Duxun Tan's work include Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers) and Advanced Breast Cancer Therapies (1 paper). Duxun Tan is often cited by papers focused on Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers) and Advanced Breast Cancer Therapies (1 paper). Duxun Tan collaborates with scholars based in China. Duxun Tan's co-authors include Jindong Xie, Yutian Zou, Xiaoming Xie, Yuhui Tang, Linyu Wu, Chau‐Wei Wong, Shaoquan Zheng, Xinpei Deng, Yue Zhang and W. H. Tian and has published in prestigious journals such as International Journal of Environmental Research and Public Health, BioMed Research International and Frontiers in Public Health.

In The Last Decade

Duxun Tan

8 papers receiving 337 citations

Hit Papers

Leveraging diverse cell-death patterns to predict the pro... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duxun Tan China 7 191 148 141 81 50 8 337
Christoph Minichsdorfer Austria 13 198 1.0× 119 0.8× 172 1.2× 142 1.8× 25 0.5× 33 428
Ganxun Li China 12 232 1.2× 119 0.8× 170 1.2× 108 1.3× 24 0.5× 29 421
Kang Wang China 11 109 0.6× 128 0.9× 78 0.6× 118 1.5× 56 1.1× 40 366
Maedeh Barahman Iran 9 130 0.7× 168 1.1× 67 0.5× 106 1.3× 21 0.4× 31 357
Jamal Carter United States 12 66 0.3× 157 1.1× 84 0.6× 69 0.9× 17 0.3× 19 339
Harlinde De Schutter Belgium 9 179 0.9× 64 0.4× 144 1.0× 97 1.2× 16 0.3× 12 360
Mathieu Pecqueux Germany 10 141 0.7× 54 0.4× 110 0.8× 117 1.4× 21 0.4× 18 317
Yeqian Feng China 11 266 1.4× 49 0.3× 228 1.6× 75 0.9× 32 0.6× 28 480
Yuqiu Xu China 9 123 0.6× 123 0.8× 110 0.8× 126 1.6× 59 1.2× 18 288

Countries citing papers authored by Duxun Tan

Since Specialization
Citations

This map shows the geographic impact of Duxun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duxun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duxun Tan more than expected).

Fields of papers citing papers by Duxun Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duxun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duxun Tan. The network helps show where Duxun Tan may publish in the future.

Co-authorship network of co-authors of Duxun Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Duxun Tan. A scholar is included among the top collaborators of Duxun Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duxun Tan. Duxun Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Xie, Jindong, Yutian Zou, Ting Gao, et al.. (2022). Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Cancer Control. 29. 2905517278–2905517278. 16 indexed citations
2.
Zou, Yutian, Jindong Xie, Shaoquan Zheng, et al.. (2022). Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. International Journal of Surgery. 107. 106936–106936. 248 indexed citations breakdown →
3.
Lu, Wenfeng, Fengjiao Zheng, Zhi Li, et al.. (2022). Association Between Environmental and Socioeconomic Risk Factors and Hepatocellular Carcinoma: A Meta-Analysis. Frontiers in Public Health. 10. 741490–741490. 13 indexed citations
4.
Zhang, Yue, Duxun Tan, Yi Xie, et al.. (2022). CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis. Journal of Oncology. 2022. 1–11. 13 indexed citations
5.
Tan, Xinyu, et al.. (2019). circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma. Current Cancer Drug Targets. 20(4). 288–294. 13 indexed citations
6.
Huang, Yuanjian, et al.. (2018). miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β. Journal of Cancer Research and Therapeutics. 14(1). 111–118. 21 indexed citations
7.
Shi, Jianwei, Duxun Tan, Rui Liu, et al.. (2017). Unequal Distribution of Overweight Adolescents in Immigrant-Rich Areas: Analysis of Disparities among Public and Private School Students in Shanghai, China. International Journal of Environmental Research and Public Health. 14(3). 252–252. 5 indexed citations
8.
Shi, Jianwei, Chenghua Jiang, Duxun Tan, et al.. (2016). Advancing Implementation of Evidence-Based Public Health in China: An Assessment of the Current Situation and Suggestions for Developing Regions. BioMed Research International. 2016. 1–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026